Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.

Genes & development | 2015

Copy number heterogeneity is a prominent feature within tumors. The molecular basis for this heterogeneity remains poorly characterized. Here, we demonstrate that hypoxia induces transient site-specific copy gains (TSSGs) in primary, nontransformed, and transformed human cells. Hypoxia-driven copy gains are not dependent on HIF1α or HIF2α; however, they are dependent on the KDM4A histone demethylase and are blocked by inhibition of KDM4A with a small molecule or the natural metabolite succinate. Furthermore, this response is conserved at a syntenic region in zebrafish cells. Regions with site-specific copy gain are also enriched for amplifications in hypoxic primary tumors. These tumors exhibited amplification and overexpression of the drug resistance gene CKS1B, which we recapitulated in hypoxic breast cancer cells. Our results demonstrate that hypoxia provides a biological stimulus to create transient site-specific copy alterations that could result in heterogeneity within tumors and cell populations. These findings have major implications in our understanding of copy number heterogeneity and the emergence of drug resistance genes in cancer.

Pubmed ID: 25995187 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: CA059267
  • Agency: NCI NIH HHS, United States
    Id: U24 CA143845
  • Agency: NCI NIH HHS, United States
    Id: C06 CA059267
  • Agency: CIHR, Canada
  • Agency: NCI NIH HHS, United States
    Id: R01 CA160458
  • Agency: NCCDPHP CDC HHS, United States
    Id: DP1 GM105378
  • Agency: Wellcome Trust, United Kingdom
  • Agency: NCI NIH HHS, United States
    Id: U24CA143845
  • Agency: NCI NIH HHS, United States
    Id: 1R01CA160458
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM097360
  • Agency: NIGMS NIH HHS, United States
    Id: R01GM097360
  • Agency: Wellcome Trust, United Kingdom
    Id: 092809/Z/10/Z
  • Agency: NIGMS NIH HHS, United States
    Id: DP1 GM105378

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Covance (tool)

RRID:SCR_001224

A contract research organization providing drug development and animal testing services. Under the name Covance Research Products Inc., based in Denver, Pennsylvania, the company also deals in the import, breeding and sale of laboratory animals. It breeds dogs, rabbits, guinea pigs, non-human primates, and pigs, and runs the largest non-human primate laboratory in Germany. (Wikipedia)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

SK-N-AS (tool)

RRID:CVCL_1700

Cell line SK-N-AS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MM1.S (tool)

RRID:CVCL_8792

Cell line MM1.S is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-231 (tool)

RRID:CVCL_0062

Cell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions